Safety, Efficacy and Cost Analysis of Rivaroxaban versus Fondaparinux for Thromboprophylaxis after Joint Replacement at an Inpatient Rehabilitation Facility
Abstract:This study compares safety, efficacy, and cost of the new oral Factor Xa inhibitor rivaroxaban to fondaparinux, an injectable anticoagulant, for prevention of VTE (venous thromboembolism) after hip or knee arthroplasty within an IRF (inpatient rehabilitation facility). In this retrospective review, data was collected on the patients that were either status post total knee arthroplasty or total hip arthroplasty, admitted to the IRF over a 24 month period. All patients identified for inclusion in the study recei… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.